Skip to content
Research Article Open access CC BY 4.0

Studies on Serum T3, T4, TSH, Progesterone and Oestrogen in Cardiovascular Disease Patients

Prince Henry Nnadi, Maryjane Nwachukwu, Chidiebere Ikechukwu Ikaraoha, Jaachi Winifred Mbachu, Kris Azubuike Mmerenini, Chizaram Winners Ndubueze, Charlotte Chinwendu Iwuji

International Journal of Biochemistry Research & Review · pp. 33–39 · Published 15 Feb 2024

10.9734/ijbcrr/2024/v33i2856

Abstract

Aim: This research was done to ascertain if thyroid hormones and female sex hormones (progesterone and estrogen) play a role or are a risk factor in the development of cardiovascular diseases. Study Design: This is an observational study, specifically a case-control study. Place and Duration of Study: This study was conducted at Enugu State University Teaching Hospital for six months. Methodology: Blood samples were collected from 20 persons with cardiovascular disease. The sera from the study subjects were estimated for T3, T4, and TSH using the ELISA technique. The same parameters were estimated in 20 healthy individuals, and the results from both groups were analysed using SPSS version 21. Results: There were no significant differences in serum T3, T4 and TSH, Progesterone and Estradiol (p=0.236, p=0.834, p=0.412, p=0.995 and p=0.512, respectively) in cardiovascular disease patients compared with controls. There were no significant differences in serum T3, Progesterone, Estradiol and TSH (p=0.443, p=0.291, p=0.612 and p=0.550, respectively) in male cardiovascular disease patients compared to female cardiovascular disease patients. There was a significantly higher level of T4 (p=0.042) in male cardiovascular disease patients compared to female cardiovascular disease patients. A significant negative correlation of serum TSH with T4 (r=-0.759, p=0.000) in cardiovascular disease patients. There was no significant correlation of serum TSH with T3 (r=-0.131, p=0.560) in cardiovascular disease patients. There was a significant positive correlation of Serum Progesterone with Estradiol (r=0.815, p=0.000) in cardiovascular disease patients. Conclusion: T4, T3, and TSH serum levels may not be associated with the development of cardiovascular diseases in this environment. Also, serum progesterone may have a linear association with estradiol in cardiovascular disease patients.

Heart disease sex hormones thyroid hormones pituitary gland menopause

References (21)

  1. 1 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 [DOI]
  2. 2 Long-Term Trends in the Incidence of and Survival with Heart Failure [DOI]
  3. 3 Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons [DOI]
  4. 4 Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations [DOI]
  5. 5 Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study [DOI]
  6. 6 Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease [DOI]
  7. 7 Impaired Endothelium-Dependent Vasodilatation in Subclinical Hypothyroidism: Beneficial Effect of Levothyroxine Therapy [DOI]
  8. 8 Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein [DOI]
  9. 9 Thyroid dysfunction and serum lipids: a community‐based study [DOI]
  10. 10 Hyperthyroidism: A Secondary Cause of Isolated Systolic Hypertension [DOI]
  11. 11 Risk Factors for Sudden Cardiac Death in Post-Menopausal Women [DOI]
  12. 12 Low Free Testosterone is Associated with Heart Failure Mortality in Older Men Referred for Coronary Angiography [DOI]
  13. 13 Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans [DOI]
  14. 14 A NEW STRATEGY FOR THYROID FUNCTION TESTING [DOI]
  15. 15 Widmann’s Clinical Interpretation of Laboratory Tests [DOI]
  16. 16 Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade [DOI]
  17. 17 Immunoradiometric assay of thyrotropin as a "first-line" thyroid-function test in the routine laboratory. [DOI]
  18. 18 Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study [DOI]
  19. 19 DETERMINATION OF PROTEIN-BOUND IODINE [DOI]
  20. 20 THE RELATIONSHIP BETWEEN LEVELS OF THYROID STIMULATING HORMONE AND OF THYROXINE AND TRIIODOTHYRONINE IN BLOOD OF HYPOTHYROID PATIENTS [DOI]
  21. 21 Thyroid hormone treatment: new insights into an old therapy [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

45

Page views

0

PDF downloads

8

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.